Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KW6V
|
|||
| Former ID |
DNC012985
|
|||
| Drug Name |
3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine
|
|||
| Synonyms |
CHEMBL206465; 3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H24N4O
|
|||
| Canonical SMILES |
C1COCCN1CCNC2=NC3=CC=CC=C3N=C2CC4=CC=CC=C4
|
|||
| InChI |
1S/C21H24N4O/c1-2-6-17(7-3-1)16-20-21(22-10-11-25-12-14-26-15-13-25)24-19-9-5-4-8-18(19)23-20/h1-9H,10-16H2,(H,22,24)
|
|||
| InChIKey |
JEKWAIMSNCODJF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1753-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.